<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607112447200</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607112447200</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Communications</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Micronutrient, Antioxidant, and Oxidative Stress Status in Children With Severe Cerebral Palsy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Schoendorfer</surname><given-names>Niikee C.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112447200">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Vitetta</surname><given-names>Luis</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-0148607112447200">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sharp</surname><given-names>Nita</given-names></name>
<xref ref-type="aff" rid="aff1-0148607112447200">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>DiGeronimo</surname><given-names>Michelle</given-names></name>
<xref ref-type="aff" rid="aff3-0148607112447200">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wilson</surname><given-names>Gary</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3-0148607112447200">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Coombes</surname><given-names>Jeff S.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3-0148607112447200">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Boyd</surname><given-names>Roslyn</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff4-0148607112447200">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Davies</surname><given-names>Peter S. W.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112447200">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0148607112447200"><label>1</label>Children’s Nutrition Research Centre</aff>
<aff id="aff2-0148607112447200"><label>2</label>Centre for Integrative and Molecular Medicine</aff>
<aff id="aff3-0148607112447200"><label>3</label>Exercise and Oxidative Stress Research Group, School of Human Movements</aff>
<aff id="aff4-0148607112447200"><label>4</label>Queensland Cerebral Palsy and Rehabilitation Research Centre, The University of Queensland, Brisbane, Australia</aff>
<author-notes>
<corresp id="corresp1-0148607112447200">Niikee C. Schoendorfer, Children’s Nutrition Research Centre, The University of Queensland, Royal Children’s Hospital, Herston, Australia 4029. Email: <email>n.schoendorfer@uq.edu.au</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>37</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>101</lpage>
<history>
<date date-type="received">
<day>8</day>
<month>2</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>4</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p><italic>Background</italic>: Markers indicative of micronutrient and antioxidant status in children with cerebral palsy (CP) were explored due to these children’s well-documented issues with food intake and the limited biochemical literature. <italic>Materials and Methods</italic>: Children aged 4 to 12 years with marked CP (n = 24) and controls (n = 24) were recruited. The CP group represented orally (O) or enterally fed (E) children. Concentrations of red cell folate (RCF), magnesium, superoxide dismutase (SOD), glutathione reductase, and peroxidase were measured, as well as serum methylmalonic acid and vitamin C. Plasma hemoglobin, C-reactive protein, α-tocopherol, cholesterol, zinc, protein carbonyls, and total antioxidant capacity were also quantified. <italic>Results</italic>: Data are reported as mean (SD) and <italic>z</italic> scores where values differ with age. Many similarities existed, but zinc <italic>z</italic> scores were reduced in O (–1.10 [0.83]) vs controls (–0.54 [0.54]) (<italic>P</italic> &lt; .05), as well as for glutathione reductase in O (10.15 [1.69]) vs E (12.22 [2.41]) and controls (11.51 [1.67]) (<italic>P</italic> &lt; .05). RCF was greatly increased in E (1422 [70]) vs O (843 [80]) and controls (820 [43]) (<italic>P</italic> &lt; .001). SOD was decreased in E (24.3 [1.4]) vs controls (27.0 [2.8]) (<italic>P</italic> &lt; .05). <italic>Conclusion</italic>: Considering their vast impact on physiology, micronutrients should be routinely monitored in orally fed children with swallowing disorders and dietary limitations. Excessive intakes, particularly long term in enterally fed children, should also be monitored in view of their potential for competitive inhibition, particularly at high levels.</p>
</abstract>
<kwd-group>
<kwd>micronutrients</kwd>
<kwd>enteral feeding</kwd>
<kwd>oxidative stress</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0148607112447200">
<title>Clinical Relevancy Statement</title>
<p>Information on micronutrient status using functional biochemical indicators is an important area of child malnutrition, considering the inherent issues using commonly practiced static testing methods. The findings of this study highlight the need for consideration to be placed on nutrition imbalances, as opposed to stand-alone issues with deficiency in children with feeding issues such as in cerebral palsy.</p>
</sec>
<sec id="section2-0148607112447200" sec-type="intro">
<title>Introduction</title>
<p>Cerebral palsy (CP) is the most common disability identified in approximately 1 per 500 live births.<sup><xref ref-type="bibr" rid="bibr1-0148607112447200">1</xref></sup> Children with CP commonly have feeding difficulties, due to involuntary muscle spasms and spasticity, which can affect their swallowing ability.<sup><xref ref-type="bibr" rid="bibr2-0148607112447200">2</xref></sup> This has a significant influence on their nutrient intake and thus general health and life expectancy.<sup><xref ref-type="bibr" rid="bibr3-0148607112447200">3</xref></sup></p>
<p>Optimal nutrition status may significantly affect health outcomes via its potential to improve immune system function<sup><xref ref-type="bibr" rid="bibr4-0148607112447200">4</xref></sup> and enhance healing mechanisms of both soft and connective tissues.<sup><xref ref-type="bibr" rid="bibr5-0148607112447200">5</xref>,<xref ref-type="bibr" rid="bibr6-0148607112447200">6</xref></sup> Subclinical deficiencies are known to impair numerous biological processes, including immune function.<sup><xref ref-type="bibr" rid="bibr7-0148607112447200">7</xref></sup> Many micronutrient deficiencies, including riboflavin, folic acid, and vitamins A, B<sub>6</sub>, B<sub>12</sub>, C, and D, have been documented to inhibit the formation of specific antibodies against invading pathogens,<sup><xref ref-type="bibr" rid="bibr8-0148607112447200">8</xref></sup> and many are also required as antioxidants for free radical scavenging.<sup><xref ref-type="bibr" rid="bibr9-0148607112447200">9</xref></sup> Specific micronutrients such as vitamins A and C, as well as vitamin B<sub>6</sub> and folic acid, seem to play a larger role in immune system function than most other nutrients, with the latter also being especially important in protein and nucleic acid metabolism.<sup><xref ref-type="bibr" rid="bibr10-0148607112447200">10</xref></sup> These particular nutrients also play a role in maintaining integrity and metabolic function of most mitotic tissues. In contrast, some of the other B vitamins more precisely function in metabolism with fewer effects on immunity.<sup><xref ref-type="bibr" rid="bibr11-0148607112447200">11</xref></sup></p>
<p>Aside from acting as antioxidants or immune system modulators, micronutrients are essential to intermediary metabolism as cofactors in numerous enzymatic reactions or in nonenzymatic physiological functions. These include, although are not limited to, hematopoiesis and cell proliferation and differentiation,<sup><xref ref-type="bibr" rid="bibr11-0148607112447200">11</xref>,<xref ref-type="bibr" rid="bibr12-0148607112447200">12</xref></sup> which are essential for growth and development. Due to increasing body mass during these periods, all children have an increased need for trace elements, predominantly during rapid growth in infancy and in puberty.<sup><xref ref-type="bibr" rid="bibr13-0148607112447200">13</xref></sup> These alterations in requirement are mainly to accommodate the need for structural syntheses and enzyme production.<sup><xref ref-type="bibr" rid="bibr10-0148607112447200">10</xref></sup></p>
<p>Assessment of micronutrient status often relies on the quantification of element concentrations in a variety of components and cells in the blood, with this strategy based on the assumption that circulating mineral concentrations reflect organ and tissue mineral contents. Although these methods are commonly used, it has not been a sensitive approach for the evaluation of total body nutrition status of mineral elements.<sup><xref ref-type="bibr" rid="bibr14-0148607112447200">14</xref></sup></p>
<p>Micronutrients are also disseminated among circulating, storage, and tissue pools, depending on the chemistry of their environment. Physiologic stress, intercompartmental fluid shifts, acid-base balance, and recent dietary intake can all affect sequestration of nutrients within a particular pool. Nutrient levels in both plasma and serum may also appear to be sufficient, even when there is verification of functional impairment due to the serum concentrations of some nutrients, such as calcium and vitamin A, being strongly homeostatically regulated,<sup><xref ref-type="bibr" rid="bibr15-0148607112447200">15</xref></sup> therefore providing little information on total body status.</p>
<p>As much of the nutrition research in children with CP surrounds the concepts of energy and deficiency, the aim of this study was to assess body status of a range of micronutrients along with measures of antioxidant capacity and oxidative stress. Functional laboratory tests were used where appropriate and available, such as measuring the activity of enzymes that require a nutrient as a coenzyme or prosthetic group. Examination of the extent of functional impairments during a specific nutrient deficiency may have greater biological implication than the commonly used static laboratory tests.</p>
</sec>
<sec id="section3-0148607112447200" sec-type="methods">
<title>Method</title>
<p>Children with marked CP (n = 24), aged between 4 and 12 years (mean [SD], 7 years, 7 months [2 years, 6 months]), were recruited from the Royal Children’s Hospital, Brisbane, Australia. These children were classified on the Gross Motor Function Classification Scale (GMFCS) as either level IV (n = 11) or V (n = 13), which consists of children who are nonambulatory. This group was further divided into those who are orally fed (n = 15) and enterally fed (n = 9). A control group, which included age-matched, typically developing healthy children (n = 24; mean [SD] age, 7 years, 4 months [2 years]), were recruited through a range of advertising mediums. This study was conducted according to the guidelines in the Declaration of Helsinki, and all procedures involving human participants/patients were approved by the ethics committees of the Royal Children’s Hospital (2007/117), The University of Queensland (2006000409), and the Cerebral Palsy League of Queensland (2008/2009 1021). Written informed consent was obtained from all participants’ parents or guardians.</p>
<p>Exclusion criteria included coexistence of specific chronic diseases such as renal, cardiac, or identified metabolic disorders, as well as gastric resection, which may otherwise confound results.</p>
<p>Fasting blood samples were collected from participants and separated into an EDTA-anticoagulant tube for plasma zinc and hemoglobin, red blood cell magnesium, and folate. Lithium heparin plasma tubes were used for C-reactive protein, α-tocopherol, and cholesterol, with the red cells used to quantify glutathione peroxidase and reductase. Serum was collected for methylmalonic acid (MMA), homocysteine, and vitamin C, with the latter requiring further stabilization following the method used by Vuilleumier and Keck<sup><xref ref-type="bibr" rid="bibr16-0148607112447200">16</xref></sup> and adapted for a microplate reader (FLUOstar Optima; BMG Lab Tech, Ortenberg, Germany) using excitation and emission wavelengths of 355 and 460 nm, respectively.</p>
<p>Blood samples for additional antioxidant parameters were collected in tubes containing dipotassium EDTA, and serum was mixed in a ratio of 1:1 with a solution of 2 g dithiothreitol (DTT) and 0.2 g EDTA per liter of 350 mmol/L HClO<sub>4</sub> as a preservative, until subsequent analysis, in accordance with the protocol previously described.<sup><xref ref-type="bibr" rid="bibr17-0148607112447200">17</xref></sup></p>
<p>Plasma protein carbonyls were measured as a marker for protein oxidation, in duplicate, using a microplate reader (FLUOstar Optima; BMG Lab Tech) according to published methods.<sup><xref ref-type="bibr" rid="bibr18-0148607112447200">18</xref>,<xref ref-type="bibr" rid="bibr19-0148607112447200">19</xref></sup> Carbonyl content was calculated from absorbance at wavelengths of 370 and 650 nm and expressed relative to protein concentration, which was determined using a bicinchoninic acid protein assay (BCA Protein assay kit; Thermo Scientific, Waltham, MA).</p>
<p>Blood plasma was analyzed for total antioxidant capacity (TAC) activity, and blood erythrocytes were analyzed for superoxide dismutase (SOD) activity using modified versions of assays described in other studies<sup><xref ref-type="bibr" rid="bibr20-0148607112447200">20</xref><xref ref-type="bibr" rid="bibr21-0148607112447200"/>-<xref ref-type="bibr" rid="bibr22-0148607112447200">22</xref></sup> using an automated spectrophotometer (Cobas Mira; Roche, Basel, Switzerland).</p>
<p>Red cell folate (RCF) was tested using the folate assay (competitive binding receptor assay) on the Beckman Coulter DXi analyzer (Beckman Coulter Synchron Clinical System; Beckman Coulter, Brea, CA), whereas C-reactive protein was directly analyzed with the same instrument. Hemoglobin assessment was performed on the Sysmex XE2100 hematology analyzer (Sysmex Corporation, Kobe, Japan). Concentrations of MMA were calculated using gas chromatography–mass spectrometry (GC-MS) with isotope-labeled internal standards and modified methods previously described.<sup><xref ref-type="bibr" rid="bibr23-0148607112447200">23</xref></sup></p>
<p>The <italic>z</italic> scores were calculated for values that are known to vary with age and gender, such as plasma zinc, α-tocopherol, hemoglobin, and cholesterol. These were calculated from previously published reference material.<sup><xref ref-type="bibr" rid="bibr24-0148607112447200">24</xref></sup> A ratio of α-tocopherol to total cholesterol was used as abnormal lipid concentrations may confound the interpretation of α-tocopherol status, due to it circulating in blood mainly with low-density lipoproteins. To overcome this effect, plasma α-tocopherol levels have been correlated to lipid fractions, with the plasma α-tocopherol/cholesterol ratio found to be the most convenient to perform the indicator.<sup><xref ref-type="bibr" rid="bibr25-0148607112447200">25</xref></sup></p>
<p>Statistical analyses were conducted using Microsoft Office Excel 2007 (Microsoft Corp, Redmond, WA), with comparisons between means obtained via analysis of variance (ANOVA). <italic>P</italic> values were calculated via the post hoc least significant difference test. <italic>P</italic> values below .05 were considered statistically significant. As no previous data exist in this area, a sample size of 16 was selected as it would detect a statistically significant difference if the means between the groups varied by 1 standard deviation.</p>
</sec>
<sec id="section4-0148607112447200" sec-type="results">
<title>Results</title>
<p>Participant characteristics, including anthropometric data, are outlined in <xref ref-type="table" rid="table1-0148607112447200">Table 1</xref>. Resultant data are found in <xref ref-type="table" rid="table2-0148607112447200">Table 2</xref>. Micronutrient status assessments via pathology testing revealed no significant differences between the groups for concentrations of red cell glutathione peroxidase as a functional measure of selenium status, red cell magnesium, hemoglobin <italic>z</italic> score, serum α-tocopherol <italic>z</italic> score/cholesterol <italic>z</italic> score ratio, protein carbonyl, or TAC was established. Red cell enzyme glutathione reductase, as a functional measure of riboflavin, was lower in orally fed children compared with the other children, whereas the activity of this enzyme after the addition of flavin adenine dinucleotide (FAD effect) was significantly lower in the enterally fed children. SOD activity was also found significantly reduced in the enterally fed children compared with the other groups.</p>
<table-wrap id="table1-0148607112447200" position="float">
<label>Table 1.</label>
<caption>
<p>Participant Characteristics.</p>
</caption>
<graphic alternate-form-of="table1-0148607112447200" xlink:href="10.1177_0148607112447200-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="2">Cerebral Palsy<hr/></th>
<th/>
</tr>
<tr>
<th/>
<th align="center">Enterally Fed</th>
<th align="center">Orally Fed</th>
<th align="center">Controls</th>
</tr>
</thead>
<tbody>
<tr>
<td>Number</td>
<td>9</td>
<td>15</td>
<td>24</td>
</tr>
<tr>
<td>Age, y, mean (SD) [95% CI]</td>
<td>8.1 (2.9) [6.2 to 10.0]</td>
<td>7.1 (2.1) [6.0 to 8.2]</td>
<td>7.3 (2.0) [6.5 to 8.1]</td>
</tr>
<tr>
<td colspan="4">Gender, No.</td>
</tr>
<tr>
<td> Male</td>
<td>7</td>
<td>9</td>
<td>13</td>
</tr>
<tr>
<td> Female</td>
<td>2</td>
<td>6</td>
<td>11</td>
</tr>
<tr>
<td colspan="4">Gross Motor Function Classification Scale, No.</td>
</tr>
<tr>
<td> IV</td>
<td>2</td>
<td>7</td>
<td>NA</td>
</tr>
<tr>
<td> V</td>
<td>7</td>
<td>8</td>
<td>NA</td>
</tr>
<tr>
<td>Height <italic>z</italic> score, mean (SD) [95% CI]</td>
<td><bold>−1.75 (0.90) [−2.06 to −1.43]</bold></td>
<td><bold>−1.68 (1.0) [−2.37 to −1.13]</bold></td>
<td>0.10 (0.82) [−0.23 to 0.43] P <bold>&lt; .001</bold></td>
</tr>
<tr>
<td>Weight <italic>z</italic> score, mean (SD) [95% CI]</td>
<td><bold>−0.73 (1.24) [−1.59 to 0.1]</bold></td>
<td><bold>−1.92 (1.59) [−2.73 to −1.11]</bold></td>
<td>0.70 (0.84) [0.36 to 1.04] P <bold>&lt; .001</bold></td>
</tr>
<tr>
<td>BMI <italic>z</italic> score, mean (SD) [95% CI]</td>
<td><bold>0.52 (1.01) [−0.18 to 1.22]</bold></td>
<td><bold>−1.06 (1.62) [−1.88 to −0.24]<sup><xref ref-type="table-fn" rid="table-fn2-0148607112447200">a</xref></sup></bold></td>
<td>0.83 (1.06) [0.40 to 1.26] P <bold>&lt; .001</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0148607112447200">
<p>Bold values differ significantly from controls. BMI, body mass index; CI, confidence interval; NA, not applicable.</p>
</fn>
<fn id="table-fn2-0148607112447200">
<label>a</label>
<p>Indicates differences between cerebral palsy groups.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table2-0148607112447200" position="float">
<label>Table 2.</label>
<caption>
<p>Biochemical Markers Assayed in Blood.</p>
</caption>
<graphic alternate-form-of="table2-0148607112447200" xlink:href="10.1177_0148607112447200-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="2">Cerebral Palsy<hr/></th>
<th/>
<th/>
</tr>
<tr>
<th align="left">Analyte</th>
<th align="center">Enterally Fed (n = 9)</th>
<th align="center">Orally Fed (n = 15)</th>
<th align="center">Controls (n = 24)</th>
<th align="center"><italic>P</italic> Value, ANOVA</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, y, mo</td>
<td>8, 1 (2, 10) [6.2 to 10.0]</td>
<td>7, 1 (2, 1) [6.0 to 8.2]</td>
<td>7, 4 (2, 0) [6.5 to 8.1]</td>
<td><italic>NS</italic></td>
</tr>
<tr>
<td>Plasma α-tocopherol <italic>z</italic> score/total cholesterol <italic>z</italic> score ratio</td>
<td>−1.50 (3.35)<sup><xref ref-type="table-fn" rid="table-fn4-0148607112447200">a</xref></sup> [−3.82 to 0.82]</td>
<td>1.39 (2.83)<sup><xref ref-type="table-fn" rid="table-fn4-0148607112447200">a</xref></sup> [−0.09 to 2.87]</td>
<td>1.23 (6.43) [−1.83 to 4.29]</td>
<td><italic>NS</italic></td>
</tr>
<tr>
<td>Serum vitamin C, µM</td>
<td>66.5 (19.6) [52.9 to 80.1]</td>
<td>50.8 (25.1) [38.1 to 63.5]</td>
<td>52.2 (13.05) [46.9 to 58.1]</td>
<td><italic>NS</italic></td>
</tr>
<tr>
<td>Serum-corrected calcium <italic>z</italic> score</td>
<td>0.28 (0.51) [−0.06 to 0.62]</td>
<td>−0.17 (0.82) [−0.59 to 0.25]</td>
<td>−0.26 (0.93) [−0.32 to −0.20]</td>
<td><italic>NS</italic></td>
</tr>
<tr>
<td>Serum magnesium <italic>z</italic> score</td>
<td>2.14 (2.01)<sup><xref ref-type="table-fn" rid="table-fn4-0148607112447200">a</xref></sup> [0.83 to 3.45]</td>
<td>0.65 (0.85)<sup><xref ref-type="table-fn" rid="table-fn4-0148607112447200">a</xref></sup> [0.22 to 1.08]</td>
<td>1.36 (1.24) [0.84 to 1.88]</td>
<td>&lt;.05</td>
</tr>
<tr>
<td>Plasma zinc <italic>z</italic> score</td>
<td>−1.05 (0.73) [−1.63 to −0.47]</td>
<td><bold>−1.10 (0.83) [−1.55 to −0.65]</bold></td>
<td>−0.54 (0.54) [−0.76 to −0.32]</td>
<td>&lt;.05</td>
</tr>
<tr>
<td>Hemoglobin <italic>z</italic> score</td>
<td>0.92 (2.70) [−0.84 to 2.68]</td>
<td>0.06 (1.08) [−0.49 to 0.61]</td>
<td>−0.07 (1.04) [−0.49 to 0.35]</td>
<td><italic>NS</italic></td>
</tr>
<tr>
<td>RCF, nmol/L</td>
<td><bold>1422 (70)</bold> [1286 to 1558]</td>
<td>843 (80) [686 to 1000]</td>
<td>820 (43) [756 to 884]</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Red cell magnesium, mmol/L</td>
<td>2.10 (0.14) [1.99 to 2.21]</td>
<td>2.03 (0.13) [1.96 to 2.10]</td>
<td>2.10 (0.14) [2.04 to 2.16]</td>
<td><italic>NS</italic></td>
</tr>
<tr>
<td>MMA, nmol/L</td>
<td><bold>88 (21)</bold> [74 to 102]</td>
<td>142 (101) [91 to 193]</td>
<td>157 (54) [133 to 181]</td>
<td>&lt;.05</td>
</tr>
<tr>
<td>Protein carbonyls</td>
<td>0.98 (0.30) [0.78 to 1.18]</td>
<td>1.16 (0.29) [1.01 to 1.31]</td>
<td>1.22 (0.45) [1.03 to 1.41]</td>
<td><italic>NS</italic></td>
</tr>
<tr>
<td>Red cell SOD, U/mg Hb</td>
<td><bold>24.3 (1.4) [23.3 to 25.3]</bold></td>
<td>25.7 (1.8) [24.7 to 26.7]</td>
<td>27.0 (2.8) [25.8 to 28.2]</td>
<td>&lt;.05</td>
</tr>
<tr>
<td>Red cell glutathione peroxidase, U/g Hb</td>
<td>24.11 (8.27) [18.71 to 29.51]</td>
<td>26.33 (7.83) [22.37 to 30.29]</td>
<td>29.52 (7.42) [26.49 to 32.55]</td>
<td><italic>NS</italic></td>
</tr>
<tr>
<td>Red cell glutathione reductase, U/g Hb</td>
<td>12.22 (2.41)<sup><xref ref-type="table-fn" rid="table-fn4-0148607112447200">a</xref></sup> [10.65 to 13.79]</td>
<td><bold>10.15 (1.69)<sup><xref ref-type="table-fn" rid="table-fn4-0148607112447200">a</xref></sup> [9.30 to 11.00]</bold></td>
<td>11.51 (1.67) [10.83 to 12.19]</td>
<td>&lt;.05</td>
</tr>
<tr>
<td>FAD effect</td>
<td><bold>0.03 (0.04)<sup><xref ref-type="table-fn" rid="table-fn4-0148607112447200">a</xref></sup> [0.01 to 0.05]</bold></td>
<td>0.16 (0.13)<sup><xref ref-type="table-fn" rid="table-fn4-0148607112447200">a</xref></sup> [0.09 to 0.23]</td>
<td>0.18 (0.11) [0.13 to 0.23]</td>
<td>&lt;.01</td>
</tr>
<tr>
<td>TAC</td>
<td>1.62 (0.09) [1.56 to 1.67]</td>
<td>1.60 (0.09) [1.58 to 1.62]</td>
<td>1.67 (0.09) [1.65 to 1.68]</td>
<td><italic>NS</italic></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0148607112447200">
<p>Values presented as mean (SD) [95% CI]. Bold values differ significantly from controls. ANOVA, analysis of variance; CI, confidence interval; FAD, flavin adenine dinucleotide; Hb, hemoglobin; MMA, methylmalonic acid; <italic>NS</italic>, not significant; RCF, red cell folate; SOD, superoxide dismutase; TAC, total antioxidant capacity.</p>
</fn>
<fn id="table-fn4-0148607112447200">
<label>a</label>
<p>Indicates differences between cerebral palsy groups.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>After removing zinc values that were affected by inflammation, as indicated by C-reactive protein levels, zinc was found to be lower in the orally fed group. Red cell folate was significantly higher in the enterally fed group, whereas MMA was lower in this group, suggesting adequate B<sub>12</sub> status.</p>
</sec>
<sec id="section5-0148607112447200" sec-type="discussion">
<title>Discussion</title>
<p>This study demonstrates a range of nutrition imbalances between the groups, with orally fed children possessing particular deficiencies and enterally fed children displaying certain excesses. Reductive adaptation occurs when nutrition is imbalanced and inadequate for the body’s demands. When allowed to progress over time, its continuance leads to the impairment of cell functions, as ensuing damage can no longer be rectified by the standard compensatory mechanisms.<sup><xref ref-type="bibr" rid="bibr26-0148607112447200">26</xref></sup></p>
<p>The term <italic>acute phase response</italic> (APR) is used to describe a short-term metabolic change, encompassing increased plasma levels of particular proteins and decreased levels of others. These responses occur in tissue injury such as infection, surgical or other trauma, burns, tissue infarction, and a variety of idiopathic inflammatory states.<sup><xref ref-type="bibr" rid="bibr27-0148607112447200">27</xref></sup> Several frequently used indicators of micronutrient status, such as serum or plasma iron, zinc, selenium, and copper, are also affected by the APR and may not effectively reflect micronutrient status. During an APR, there can be a redistribution of micronutrients without actual alterations in the total body content, resulting in commonly used indicators producing inaccurate measurements.<sup><xref ref-type="bibr" rid="bibr28-0148607112447200">28</xref></sup></p>
<p>After removing the zinc values of those patients with increased inflammation and hence the concomitant changes induced by an APR, zinc was found to be significantly lower in the orally fed group. A further consideration for zinc is that it is required in sufficient amounts to maintain vitamin A status due to its regulatory role in vitamin A transport via synthesis of retinol-binding protein. Zinc is also an indispensible enzyme cofactor for the vitamin A metabolic pathway, which requires oxidative conversion from retinol to retinaldehyde, as commonly described in the visual cycle of the retina.<sup><xref ref-type="bibr" rid="bibr29-0148607112447200">29</xref></sup></p>
<p>Red cell enzyme glutathione reductase, as a functional measure of riboflavin, was lower in orally fed children compared with the other groups. In deficiency, this enzyme has been associated with a variety of abnormal clinical states, including spasticity.<sup><xref ref-type="bibr" rid="bibr30-0148607112447200">30</xref></sup> The FAD effect was reduced in the enterally fed group, which has been documented in conditions such as hypoplastic anemia, drug-induced hemolytic anemia, thrombocytopenia, or a range of other disorders.<sup><xref ref-type="bibr" rid="bibr31-0148607112447200">31</xref></sup> It may also indicate sufficient riboflavin status, although in normal individuals, glutathione reductase in red cells is not saturated with its coenzyme FAD, and addition to the medium demonstrates an effect even at increasing dosages.<sup><xref ref-type="bibr" rid="bibr31-0148607112447200">31</xref></sup> An abnormally low FAD effect may occur in a negative nitrogen balance state, as erythrocytes can take up riboflavin released during tissue breakdown. This would corroborate with findings published elsewhere, documenting potential protein inadequacy in this group of enterally fed children with severe CP.<sup><xref ref-type="bibr" rid="bibr32-0148607112447200">32</xref></sup></p>
<p>Hemoglobin levels were also similar between the groups, which may be used as a broad overview indicator of long-term iron status. Because the range of hemoglobin values for normal nonanemic persons overlaps with values for persons with iron deficiency, hemoglobin should not be used as the only measure of iron status in individuals. Hemoglobin concentrations also fall only in late-stage iron deficiency anemia and therefore are a relatively insensitive measure of iron deficiency.<sup><xref ref-type="bibr" rid="bibr33-0148607112447200">33</xref></sup> Despite not being the most accurate measure of current iron levels, it is likely that all of the groups had adequate iron status, as iron is also essential to the enzyme glutathione peroxidase,<sup><xref ref-type="bibr" rid="bibr12-0148607112447200">12</xref></sup> which was found in sufficient levels in all groups. In light of this, we thought it low priority at this stage to investigate iron status any further.</p>
<p>On the other hand, the large standard deviation for hemoglobin in the enterally fed group was due to 2 children with excessive levels, accompanied also by high hematocrit and red cell counts (unpublished data). A number of the enterally fed children also had extremely elevated serum magnesium levels, and therefore the large standard deviation is once more evidenced.</p>
<p>SOD is an important metalloenzyme that protects lipid cell membranes from oxidation. In red cells, it is copper dependent and hence is used as a marker of copper deficiency, which has also been shown to increase through copper supplementation.<sup><xref ref-type="bibr" rid="bibr34-0148607112447200">34</xref></sup> Interestingly, previously published data on our cohort showed excessive intakes of micronutrients such as iron and zinc, which are known to affect copper absorption and/or metabolism<sup><xref ref-type="bibr" rid="bibr35-0148607112447200">35</xref></sup> and hence may be contributing to a potential copper deficiency.</p>
<p>Clinical signs due to insufficiencies and excesses of micronutrients occur due to longstanding changes in metabolic function. Clinical interventions generally occur once clinical signs manifest, should these be recognized.<sup><xref ref-type="bibr" rid="bibr36-0148607112447200">36</xref></sup> Marginal imbalances are, however, seldom addressed as subclinical micronutrient dysregulation can lack clinical signs altogether despite causing metabolic changes. Any alteration in metabolic function should be a convincing reason for intervention to optimize the physiological function—and hence health and well-being—of the patient.</p>
<p>In light of the findings outlined in this article, further research should investigate nutrition quality in these children and incorporate a myriad of nutrition components. These should also not be limited to standard assessments, as all nutrients perform vital activities in the body, which as a whole cannot function adequately in the absence of any components. There is a risk of deficiencies arising in orally fed children who are unable to consume adequate quantities of food, as is there a risk of excessive micronutrient consumption causing imbalances in enterally fed children, particularly those who are being administered high volumes in an attempt to achieve catch-up growth.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: none declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607112447200">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rosenbaum</surname><given-names>P</given-names></name>
<name><surname>Walter</surname><given-names>SD</given-names></name>
<name><surname>Hanna</surname><given-names>SE</given-names></name><etal/>
</person-group>. <article-title>Prognosis for gross motor function in cerebral palsy: creation of motor development curves</article-title>. <source>JAMA</source>. <year>2002</year>;<volume>288</volume>:<fpage>1357</fpage>-<lpage>1363</lpage>.</citation>
</ref>
<ref id="bibr2-0148607112447200">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rosenbaum</surname><given-names>P</given-names></name>
</person-group>. <article-title>The natural history of gross motor development in children with cerebral palsy aged 1 to 15 years</article-title>. <source>Dev Med Child Neurol</source>. <year>2007</year>;<volume>49</volume>:<fpage>724</fpage>.</citation>
</ref>
<ref id="bibr3-0148607112447200">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Strauss</surname><given-names>DJ</given-names></name>
<name><surname>Shavelle</surname><given-names>RM</given-names></name>
<name><surname>Reynolds</surname><given-names>RD</given-names></name>
<name><surname>Rosenbloom</surname><given-names>L</given-names></name>
<name><surname>Day</surname><given-names>SM</given-names></name>
</person-group>. <article-title>Survival in cerebral palsy in the last 20 years: signs of improvement?</article-title> <source>Dev Med Child Neurol</source>. <year>2007</year>;<volume>49</volume>:<fpage>86</fpage>-<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr4-0148607112447200">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Field</surname><given-names>CJ</given-names></name>
<name><surname>Johnson</surname><given-names>IR</given-names></name>
<name><surname>Schley</surname><given-names>PD</given-names></name>
</person-group>. <article-title>Nutrients and their role in host resistance to infection</article-title>. <source>J Leukoc Biol</source>. <year>2002</year>;<volume>71</volume>:<fpage>16</fpage>-<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr5-0148607112447200">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ronchetti</surname><given-names>IP</given-names></name>
<name><surname>Quaglino</surname><given-names>D</given-names><suffix>Jr</suffix></name>
<name><surname>Bergamini</surname><given-names>G</given-names></name>
</person-group>. <article-title>Ascorbic acid and connective tissue</article-title>. <source>Subcell Biochem</source>. <year>1996</year>;<volume>25</volume>:<fpage>249</fpage>-<lpage>264</lpage>.</citation>
</ref>
<ref id="bibr6-0148607112447200">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wicke</surname><given-names>C</given-names></name>
<name><surname>Halliday</surname><given-names>B</given-names></name>
<name><surname>Allen</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Effects of steroids and retinoids on wound healing</article-title>. <source>Arch Surg</source>. <year>2000</year>;<volume>135</volume>:<fpage>1265</fpage>-<lpage>1270</lpage>.</citation>
</ref>
<ref id="bibr7-0148607112447200">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhaskaram</surname><given-names>P</given-names></name>
</person-group>. <article-title>Immunobiology of mild micronutrient deficiencies</article-title>. <source>Br J Nutr</source>. <year>2001</year>;<volume>85</volume>:<fpage>75</fpage>-<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr8-0148607112447200">
<label>8.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Scrimshaw</surname><given-names>NS</given-names></name>
<name><surname>Taylor</surname><given-names>CE</given-names></name>
<name><surname>Gordon</surname><given-names>JE</given-names></name>
</person-group>. <source>Interactions of Nutrition and Infection</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organisation</publisher-name>; <year>1968</year>.</citation>
</ref>
<ref id="bibr9-0148607112447200">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Prasad</surname><given-names>AS</given-names></name>
<name><surname>Beck</surname><given-names>FW</given-names></name>
<name><surname>Bao</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress</article-title>. <source>Am J Clin Nutr</source>. <year>2007</year>;<volume>85</volume>:<fpage>837</fpage>-<lpage>844</lpage>.</citation>
</ref>
<ref id="bibr10-0148607112447200">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Landsdown</surname><given-names>A</given-names></name>
<name><surname>Sampson</surname><given-names>B</given-names></name>
<name><surname>Rowe</surname><given-names>A</given-names></name>
</person-group>. <article-title>Sequential changes in trace metal, metallothionein and calmodulin in healing skin wounds</article-title>. <source>J Anat</source>. <year>1999</year>;<volume>195</volume>:<fpage>375</fpage>-<lpage>386</lpage>.</citation>
</ref>
<ref id="bibr11-0148607112447200">
<label>11.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Gropper</surname><given-names>S</given-names></name>
<name><surname>Smith</surname><given-names>J</given-names></name>
<name><surname>Groff</surname><given-names>J</given-names></name>
</person-group>. <source>Advanced Nutrition and Human Metabolism</source>. <edition>5th ed.</edition> <publisher-loc>Belmont, CA</publisher-loc>: <publisher-name>Wadsworth/Thompson Learning</publisher-name>; <year>2009</year>.</citation>
</ref>
<ref id="bibr12-0148607112447200">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Prelack</surname><given-names>K</given-names></name>
<name><surname>Sheridan</surname><given-names>RL</given-names></name>
</person-group>. <article-title>Micronutrient supplementation in the critically ill patient: strategies for clinical practice</article-title>. <source>J Trauma</source>. <year>2001</year>;<volume>51</volume>:<fpage>601</fpage>-<lpage>620</lpage>.</citation>
</ref>
<ref id="bibr13-0148607112447200">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Salmenpera</surname><given-names>L</given-names></name>
</person-group>. <article-title>Detecting subclinical deficiency of essential trace elements in children with special reference to zinc and selenium</article-title>. <source>Clin Biochem</source>. <year>1997</year>;<volume>30</volume>:<fpage>115</fpage>-<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr14-0148607112447200">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lukaski</surname><given-names>HC</given-names></name>
<name><surname>Penland</surname><given-names>JG</given-names></name>
</person-group>. <article-title>Functional changes appropriate for determining mineral element requirements</article-title>. <source>J Nutr</source>. <year>1996</year>;<volume>126</volume>:<fpage>2354S</fpage>.</citation>
</ref>
<ref id="bibr15-0148607112447200">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hambidge</surname><given-names>M</given-names></name>
</person-group>. <article-title>Biomarkers of trace mineral intake and status</article-title>. <source>J Nutr</source>. <year>2003</year>;<volume>133</volume>:<fpage>948S</fpage>-<lpage>955S</lpage>.</citation>
</ref>
<ref id="bibr16-0148607112447200">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vuilleumier</surname><given-names>J</given-names></name>
<name><surname>Keck</surname><given-names>E</given-names></name>
</person-group>. <article-title>Flourometric assay of vitamin C in biological materials using a centrifuged analyzer with a flourescence attachment</article-title>. <source>J Micronutr Anal</source>. <year>1989</year>;<volume>5</volume>:<fpage>25</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr17-0148607112447200">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ching</surname><given-names>S</given-names></name>
<name><surname>Prins</surname><given-names>AW</given-names></name>
<name><surname>Beilby</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Stability of ascorbic acid in serum plasma prior to analysis</article-title>. <source>Ann Clin Biochem</source>. <year>2002</year>;<volume>39</volume>:<fpage>518</fpage>-<lpage>520</lpage>.</citation>
</ref>
<ref id="bibr18-0148607112447200">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stadtman</surname><given-names>ER</given-names></name>
<name><surname>Oliver</surname><given-names>CN</given-names></name>
</person-group>. <article-title>Metal-catalyzed oxidation of proteins; physiological consequences</article-title>. <source>J Biol Chem</source>. <year>1991</year>;<volume>266</volume>:<fpage>2005</fpage>-<lpage>2008</lpage>.</citation>
</ref>
<ref id="bibr19-0148607112447200">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reznick</surname><given-names>AZ</given-names></name>
<name><surname>Cross</surname><given-names>CE</given-names></name>
<name><surname>Hu</surname><given-names>ML</given-names></name>
</person-group>. <article-title>Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation</article-title>. <source>Biochem J</source>. <year>1992</year>;<volume>286</volume>:<fpage>607</fpage>-<lpage>611</lpage>.</citation>
</ref>
<ref id="bibr20-0148607112447200">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wheeler</surname><given-names>CR</given-names></name>
<name><surname>Salzman</surname><given-names>JA</given-names></name>
<name><surname>Elsayed</surname><given-names>NM</given-names></name>
</person-group>. <article-title>Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity</article-title>. <source>Anal Biochem</source>. <year>1990</year>;<volume>184</volume>:<fpage>193</fpage>-<lpage>199</lpage>.</citation>
</ref><ref id="bibr21-0148607112447200">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rice-Evans</surname><given-names>C</given-names></name>
<name><surname>Miller</surname><given-names>NJ</given-names></name>
</person-group>. <article-title>Total antioxidant status in plasma and body fluids</article-title>. <source>Methods Enzymol</source>. <year>1994</year>;<volume>234</volume>:<fpage>279</fpage>-<lpage>293</lpage>.</citation>
</ref>
<ref id="bibr22-0148607112447200">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oyanagui</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Reevaluation of assay methods and establishment of kit for superoxide dismutase activity</article-title>. <source>Anal Biochem</source>. <year>1984</year>;<volume>142</volume>:<fpage>290</fpage>-<lpage>296</lpage>.</citation>
</ref>
<ref id="bibr23-0148607112447200">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stabler</surname><given-names>SP</given-names></name>
<name><surname>Lindenbaum</surname><given-names>J</given-names></name>
<name><surname>Savage</surname><given-names>DG</given-names></name>
<name><surname>Allen</surname><given-names>RH</given-names></name>
</person-group>. <article-title>Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency</article-title>. <source>Blood</source>. <year>1993</year>;<volume>81</volume>:<fpage>3404</fpage>-<lpage>3413</lpage>.</citation>
</ref>
<ref id="bibr24-0148607112447200">
<label>24.</label>
<citation citation-type="book">
<person-group person-group-type="editor">
<name><surname>Soldin</surname><given-names>SJ</given-names></name>
<name><surname>Brugnara</surname><given-names>C</given-names></name>
<name><surname>Wong</surname><given-names>EC</given-names></name>
</person-group>, eds. <source>Pediatric Reference Intervals</source>. <edition>6th ed.</edition> <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>AACC Press</publisher-name>; <year>2007</year>.</citation>
</ref>
<ref id="bibr25-0148607112447200">
<label>25.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Gibson</surname><given-names>R</given-names></name>
</person-group>. <source>Principles of Nutritional Assessment</source>. <edition>2nd ed.</edition> <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2005</year>.</citation>
</ref>
<ref id="bibr26-0148607112447200">
<label>26.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Jackson</surname><given-names>AA</given-names></name>
</person-group>. <article-title>Severe malnutrition</article-title>. In: <person-group person-group-type="editor">
<name><surname>Warrell</surname><given-names>DA</given-names></name>
<name><surname>Cox</surname><given-names>TM</given-names></name>
<name><surname>Firth</surname><given-names>JD</given-names></name>
</person-group> eds. <source>Oxford Textbook of Medicine</source>. <edition>4th ed.</edition> <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2003</year>.</citation>
</ref>
<ref id="bibr27-0148607112447200">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kushner</surname><given-names>I</given-names></name>
</person-group>. <article-title>The phenomenon of the acute phase response: C-reactive protein and the plasma protein response to tissue injury</article-title>. <source>Ann N Y Acad Sci</source>. <year>1982</year>;<volume>389</volume>:<fpage>39</fpage>-<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr28-0148607112447200">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wieringa</surname><given-names>FT</given-names></name>
<name><surname>Dijkhuizen</surname><given-names>MA</given-names></name>
<name><surname>West</surname><given-names>CE</given-names></name>
<name><surname>Northrop-Clewes</surname><given-names>CA</given-names></name>
<name><surname>Muhilal</surname></name>
</person-group>. <article-title>Estimation of the effect of the acute phase response on indicators of micronutrient status in Indonesian infants</article-title>. <source>J Nutr</source>. <year>2002</year>;<volume>132</volume>:<fpage>3061</fpage>-<lpage>3066</lpage>.</citation>
</ref>
<ref id="bibr29-0148607112447200">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Christian</surname><given-names>P</given-names></name>
<name><surname>West</surname><given-names>K</given-names></name>
</person-group>. <article-title>Interactions between zinc and vitamin A: an update</article-title>. <source>Am J Clin Nutr</source>. <year>1998</year>;<volume>68</volume> <fpage>435441S</fpage>.</citation>
</ref>
<ref id="bibr30-0148607112447200">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beutler</surname><given-names>E</given-names></name>
</person-group>. <article-title>Glutathione reductase: stimulation in normal subjects by riboflavin supplementation</article-title>. <source>Science</source>. <year>1969</year>;<volume>165</volume>:<fpage>613</fpage>-<lpage>615</lpage>.</citation>
</ref>
<ref id="bibr31-0148607112447200">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beutler</surname><given-names>E</given-names></name>
</person-group>. <article-title>Effect of flavin compounds on glutathione reductase activity: in vivo and in vitro studies</article-title>. <source>J Clin Invest</source>. <year>1969</year>;<volume>48</volume>:<fpage>1957</fpage>-<lpage>1966</lpage>.</citation>
</ref>
<ref id="bibr32-0148607112447200">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schoendorfer</surname><given-names>NC</given-names></name>
<name><surname>Tinggi</surname><given-names>U</given-names></name>
<name><surname>Sharp</surname><given-names>N</given-names></name>
<name><surname>Boyd</surname><given-names>R</given-names></name>
<name><surname>Vitetta</surname><given-names>L</given-names></name>
<name><surname>Davies</surname><given-names>P</given-names></name>
</person-group>. <article-title>Protein levels in enteral feeds: do these meet requirements in children with severe cerebral palsy?</article-title> <source>Br J Nutr</source>. <year>2011</year> <month>Nov</month> <volume>4</volume>:<fpage>1</fpage>-<lpage>6</lpage>. [Epub ahead of print]</citation>
</ref>
<ref id="bibr33-0148607112447200">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fairweather-Tait</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Iron</article-title>. <source>Int J Vitam Nutr Res</source>. <year>1993</year>;<volume>63</volume>:<fpage>296</fpage>-<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr34-0148607112447200">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Uauy</surname><given-names>R</given-names></name>
<name><surname>Castillo-Duran</surname><given-names>C</given-names></name>
<name><surname>Fisberg</surname><given-names>M</given-names></name>
<name><surname>Fernandez</surname><given-names>N</given-names></name>
<name><surname>Valenzuela</surname><given-names>A</given-names></name>
</person-group>. <article-title>Red cell superoxide dismutase activity as an index of human nutrition</article-title>. <source>J Nutr</source>. <year>1985</year>;<volume>115</volume>:<fpage>1650</fpage>-<lpage>1655</lpage>.</citation>
</ref>
<ref id="bibr35-0148607112447200">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schoendorfer</surname><given-names>NC</given-names></name>
<name><surname>Tinggi</surname><given-names>U</given-names></name>
<name><surname>Sharp</surname><given-names>N</given-names></name>
<name><surname>Boyd</surname><given-names>R</given-names></name>
<name><surname>Vitetta</surname><given-names>L</given-names></name>
<name><surname>Davies</surname><given-names>PSW</given-names></name>
</person-group>. <article-title>Micronutrient intakes in enterally and orally fed children with severe cerebral palsy</article-title>. <source>e-SPEN</source>. <year>2011</year>;<volume>6</volume>:<fpage>e259</fpage>-<lpage>e262</lpage>.</citation>
</ref>
<ref id="bibr36-0148607112447200">
<label>36.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Mertz</surname><given-names>W</given-names></name>
</person-group>. <article-title>Metabolism and metabolic effects of trace elements</article-title>. In: <person-group person-group-type="editor">
<name><surname>Chandra</surname><given-names>RK</given-names></name>
</person-group>, ed. <source>Trace Elements in Nutrition of Children</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Raven</publisher-name>; <volume>1985</volume>:<fpage>107</fpage>-<lpage>117</lpage>.</citation>
</ref></ref-list>
</back>
</article>